Infectious causes of acute encephalitis syndrome hospitalizations in Central India, 2018–20
…, SA Mahamuni, A Salunkhe, P Khude… - Journal of Clinical …, 2022 - Elsevier
Background We enhanced surveillance of hospitalizations of all ages for acute encephalitis
syndrome (AES) along with infectious aetiologies, including the Japanese encephalitis virus (…
syndrome (AES) along with infectious aetiologies, including the Japanese encephalitis virus (…
[HTML][HTML] Incidence of Japanese encephalitis and acute encephalitis syndrome hospitalizations in the medium-endemic region in Central India
…, VP Bondre, GN Sapkal, RG Damle, PM Khude… - Journal of Epidemiology …, 2023 - Springer
Background We estimated the incidence of Japanese encephalitis (JE) and acute encephalitis
syndrome (AES) following routine immunization with the live-attenuated SA 14-14-2 JE …
syndrome (AES) following routine immunization with the live-attenuated SA 14-14-2 JE …
[HTML][HTML] Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in …
…, S Talashi, M Belekar, R Yadav, P Khude… - The Lancet Regional …, 2024 - thelancet.com
Background There are limited global data on head-to-head comparisons of vaccine
platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination …
platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination …
Effectiveness of Japanese encephalitis vaccination among children in central India
BV Tandale, PM Khude, PS Deshmukh… - Journal of Medical …, 2023 - Wiley Online Library
Japanese encephalitis (JE) disease among children continues in central India despite
vaccination implemented in the routine immunization program. Therefore, we planned to estimate …
vaccination implemented in the routine immunization program. Therefore, we planned to estimate …
Interim results from comparison of immune responses elicited by an inactivated and a vectored SARS-CoV-2 vaccine in seronegative and seropositive participants in …
…, A Naik, S Talashi, M Belekar, R Yadav, P Khude… - medRxiv, 2023 - medrxiv.org
Background There are limited global data on head-to-head comparisons of vaccine
platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination …
platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination …
Coverage of Japanese encephalitis routine vaccination among children in central India
…, GN Sapkal, RG Damle, P Khude… - Journal of Medical …, 2023 - Wiley Online Library
We aimed to estimate the coverage of Japanese encephalitis (JE) vaccination in central
India to help explain the continued occurrence of JE disease despite routine vaccination. We …
India to help explain the continued occurrence of JE disease despite routine vaccination. We …
Epidemiology of Japanese Encephalitis in Central India after Implementing Immunization
BV Tandale, PM Khude, PS Deshmukh… - Journal of Pediatric …, 2024 - thieme-connect.com
Objective We report the epidemiology of Japanese encephalitis (JE) disease after the
implementation of routine immunization in medium-endemic districts in the states of Maharashtra …
implementation of routine immunization in medium-endemic districts in the states of Maharashtra …
[PDF][PDF] Identification of Fraudulent Phishing Emails Based On CSS Standard Technique to Explore Similarities in Web Pages
…, R Iyer, A Ramtirthakar, MSK Guru, MP Khude… - academia.edu
… Pallavi Khude for their utmost valuable guidance, their unending support and their promptness
to help us with the most diverse of problems that we have encountered along the way …
to help us with the most diverse of problems that we have encountered along the way …
Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India
BV Tandale, VP Bondre, GN Sapkal… - Journal of Clinical …, 2021 - Elsevier
Background Japanese encephalitis (JE) is the leading cause of childhood acute encephalitis
syndrome (AES) in India. We enhanced the AES surveillance in sentinel hospitals to …
syndrome (AES) in India. We enhanced the AES surveillance in sentinel hospitals to …
A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine
S Pandey, P Tripathi, A Gupta, JS Yadav - Drug delivery and translational …, 2022 - Springer
Psoriasis is an autoimmune, chronic proliferative, inflammatory skin disease with high
comorbidity. Psoriasis is not a curable disease; it can only be managed. Cyclosporine A (CyA) is …
comorbidity. Psoriasis is not a curable disease; it can only be managed. Cyclosporine A (CyA) is …